scholarly journals Portomesenteric Venous Thrombosis in an Emergency Department Patient After Laparoscopic Sleeve Gastrectomy

Cureus ◽  
2021 ◽  
Author(s):  
Connor Lawler ◽  
Briana King ◽  
Melody L Milliron
Keyword(s):  
Emergency Department ◽  
Sleeve Gastrectomy ◽  
Venous Thrombosis ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Emergency Department Patient ◽  
Portomesenteric Venous Thrombosis

scholarly journals Portomesenteric Venous Thrombosis with Bowel Ischemia after Laparoscopic Sleeve Gastrectomy

2019 ◽  
Vol 12 (3) ◽  
pp. 135-137
Author(s):  
Mohamed Abdelmohsen ◽  
Mubarak Alkandari ◽  
Samir Abdulaziz ◽  
Mohamed Alsulimy ◽  
Nagy Ismaeil
Keyword(s):  
Sleeve Gastrectomy ◽  
Venous Thrombosis ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Bowel Ischemia ◽  
Portomesenteric Venous Thrombosis

scholarly journals Portomesenteric Venous Thrombosis Post-Laparoscopic Sleeve Gastrectomy: Do Energy Systems Pose as Instigating Factor to This Infrequent Complication?

2019 ◽  
Vol 12 ◽  
pp. 117954761984350 ◽  
Author(s):  
Mohammed N Bani Hani ◽  
Abdel Rahman A Al manasra ◽  
Firas Obeidat ◽  
Mamoon H Al-Omari ◽  
Farah Bani Hani
Keyword(s):  
Sleeve Gastrectomy ◽  
Venous Thrombosis ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Splenic Vein ◽  
Energy Systems ◽  
University Hospital ◽  
Published Data ◽  
Vein Thrombosis ◽  
Portomesenteric Venous Thrombosis

Background: Portomesenteric venous thrombosis (PMVT), a rare complication after laparoscopic sleeve gastrectomy (LSG). Severe consequences are owed to a high risk of bowel ischemia. Our aim is to present a series of patients who developed PMVT after LSG, highlighting the potential role of the vessel sealer and divider as a risk factor. Methods: Medical records of seven patients who underwent LSG and developed PMVT from April 2010 to January 2019, at King Abdullah University Hospital and Jordan University Hospital, Jordan were reviewed. Our findings were studied, audited, and compared with published data. Results: A sum of 4900 patients underwent LSG, 7 (0.14%) developed PMVT. The mean age and body mass index (BMI) were 36.8 years and 45 kg/m2, respectively. Four were women. Epigastric pain radiating to the back was the presenting symptom at a median time of 9 days after surgery. Computed tomography (CT) of the abdomen confirmed the diagnosis. Five patients presented with a total portal vein thrombosis (PVT), one with splenic vein thrombosis and one with dual portal and mesenteric vein thrombosis. Conclusion: Portomesenteric venous thrombosis is a relatively uncommon complication following LSG. Early recognition is required to avoid catastrophic outcomes. The role of energy systems in the development of PMVT remains unknown and requires further elaboration.

An Unintended Consequence of Sleeve Gastrectomy: Portomesenteric Venous Thrombosis

2015 ◽  
Vol 11 (6) ◽  
pp. S31 ◽  
Author(s):  
Arthur Carlin ◽  
Jonathan Finks ◽  
Nancy Birkmeyer ◽  
Oliver Varban ◽  
Paul Kemmeter ◽  
...  
Keyword(s):  
Sleeve Gastrectomy ◽  
Venous Thrombosis ◽  
Unintended Consequence ◽  
Portomesenteric Venous Thrombosis

scholarly journals Prophylaxis with rivaroxaban after laparoscopic sleeve gastrectomy could reduce the frequency of portomesenteric venous thrombosis

2020 ◽  
Vol 102 (9) ◽  
pp. 712-716
Author(s):  
JI Rodríguez ◽  
V Kobus ◽  
I Téllez ◽  
G Pérez
Keyword(s):  
Sleeve Gastrectomy ◽  
Venous Thrombosis ◽  
Hospital Stay ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Bleeding Complications ◽  
Mesenteric Venous Thrombosis ◽  
Post Discharge ◽  
Bleeding Episodes ◽  
Group 2 ◽  
Group 1

Introduction Portal and mesenteric venous thrombosis is a rare but potentially serious complication after laparoscopic sleeve gastrectomy. There are no consistent studies that prove the safety and effectiveness of oral anticoagulant thromboprophylaxis with rivaroxaban after laparoscopic sleeve gastrectomy. The objective was to evaluate the effect of rivaroxaban on the frequency of portal and mesenteric venous thrombosis and its safety profile after laparoscopic sleeve gastrectomy. Materials and methods This retrospective analysis of prospectively collected data includes all laparoscopic sleeve gastrectomies performed by a single surgeon at Pontificia Universidad Católica de Chile Hospital between January 2009 and June 2019. All patients received low molecular weight heparin thromboprophylaxis during the whole hospital stay. Between July 2012 and June 2019, patients received additional post-discharge thromboprophylaxis with rivaroxaban. Patient demographics, impaired renal, post-surgical portal and mesenteric venous thrombosis, and bleeding episodes were registered. Results A total of 516 patients were identified; 95 patients were excluded. Results for 421 patients were analysed: 198 received only intrahospital thromboprophylaxis (group 1) and 223 received additional post-discharge thromboprophylaxis with rivaroxaban (group 2). There was no statistically significant difference between the two groups concerning age, sex and body mass index. In group 1, four cases of portal and mesenteric venous thrombosis were registered and no cases were reported in group 2 (p < 0.05). All cases occurred before 30 days after surgery. No bleeding episodes and no adverse reactions were detected in group 2. Conclusions Thromboprophylaxis during the whole hospital stay (two to three days), followed by rivaroxaban 10mg once daily for 10 days after discharge (completing in total 13–14 days of prophylaxis), could reduce cases of post-surgical portal and mesenteric venous thrombosis without an increase in bleeding complications.

Sign in / Sign up

Export Citation Format

Share Document